BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11313401)

  • 21. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
    Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
    Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.
    Kovalev GI; Franklin DS; Coffield VM; Xiong Y; Su L
    J Immunol; 2001 Sep; 167(6):3285-92. PubMed ID: 11544316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
    Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.
    Mortellaro A; Songia S; Gnocchi P; Ferrari M; Fornasiero C; D'Alessio R; Isetta A; Colotta F; Golay J
    J Immunol; 1999 Jun; 162(12):7102-9. PubMed ID: 10358154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.
    Zhang LH; Youn HD; Liu JO
    J Biol Chem; 2001 Nov; 276(47):43534-40. PubMed ID: 11557753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition.
    Flanagan WM; Crabtree GR
    Ann N Y Acad Sci; 1993 Nov; 696():31-7. PubMed ID: 8109837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin.
    Boytim ML; Lyu SC; Jung R; Krensky AM; Clayberger C
    J Immunol; 1998 Mar; 160(5):2215-22. PubMed ID: 9498760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
    Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
    J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.
    Albers MW; Williams RT; Brown EJ; Tanaka A; Hall FL; Schreiber SL
    J Biol Chem; 1993 Oct; 268(30):22825-9. PubMed ID: 8226793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
    Appleman LJ; Berezovskaya A; Grass I; Boussiotis VA
    J Immunol; 2000 Jan; 164(1):144-51. PubMed ID: 10605005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophilin sensitivity to sanglifehrin A can be correlated to the same specific tryptophan residue as cyclosporin A.
    Pemberton TJ; Kay JE
    FEBS Lett; 2003 Dec; 555(2):335-40. PubMed ID: 14644438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylacetate inhibits growth and modulates cell cycle gene expression in renal cancer cell lines.
    Franco OE; Onishi T; Umeda Y; Soga N; Wakita T; Arima K; Yanagawa M; Sugimura Y
    Anticancer Res; 2003; 23(2B):1637-42. PubMed ID: 12820434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
    Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
    Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6 A resolution.
    Kallen J; Sedrani R; Zenke G; Wagner J
    J Biol Chem; 2005 Jun; 280(23):21965-71. PubMed ID: 15772070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
    J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.